A specific inhibitors of neuroinflammation for managing Parkinson's disease
Chiral metal-organic frameworks incorporating nanozymes as specific inhibitors of neuroinflammation for managing Parkinson's disease.Bioinformatics and biochemical analyses suggest that Ptzyme@D-ZIF can inhibit neuroinflammation-induced pathways of apoptosis and ferroptosis in damaged neurons.